Extracting full value from Harmonized UK Biobank Data Investments and democratizing access to analysis ready data
Extracting full value from Harmonized UK Biobank Data Investments and democratizing access to analysis ready data
2 PagesCase Study Extracting full value from Harmonized UK Biobank Data Investments and democratizing access to analysis ready data Posted on August 13, 2020 Situation A leading pharmaceutical company received the UK Biobank cohort with a large amount (n= 500,000) of phenotypic data in support of target discovery on a deeper level. Company researchers sought to explore the UK Biobank dataset at scale, building complex queries that take multiple parameters into effect and further refine cohorts to match diseases of interest Challenge To extract its full value, the company’s data needed to be clean, easy to navigate and diverse. Ongoing curation and harmonization is also required to maintain the dataset and integrate it with other data that becomes available In-house capabilities for
